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ABBREVIATIONS AND DEFINITIONS 
 
ERP – endoscopic retrograde pancreatography 
ERC – endoscopic retrograde cholangiography 
ERCP – endoscopic retrograde cholangiopancreatography  
MRCP – magnetic resonance cholangiopancreatography 
MRI – magnetic resonance imaging 
CT – computed tomography 
US – ultrasound 
FAST – focused abdominal sonography in trauma 
MPD – main pancreatic duct 
AAST – American Association for the Surgery of Trauma 
TPN – total parental nutrition 


























Endoscopic retrograde pancreatography (ERP) has various applications in the 
diagnosis and management of pancreatic trauma.  The utility of ERP in pancreatic 
trauma presenting to a level 1 equivalent trauma centre was analysed. 
 
Methods:  
Patients who sustained pancreatic trauma and underwent ERP were identified. Patient 
demographics, mechanism of injury, time to presentation, diagnostic modalities, 
associated injuries, clinical management, endoscopic interventions and their timing, 
surgical treatment and patient outcomes were recorded. 
 
Results:  
Forty-eight patients with pancreatic trauma were referred for ERP after blunt (26), 
gunshot (15), or stab (7) injury. The average time from injury to ERP was 38 days 
(range 2 – 365). An ERP visualized the duct in 47 patients. Twenty-four patients had a 
pancreatic fistula, 12 patients had a main pancreatic duct stricture or cut-off and 10 
patients had a pseudocyst. Endoscopic interventions were pancreatic duct 
sphincterotomy (15), pancreatic duct stent (7) or pseudocyst drainage (6).  Ten patients 
demonstrated minor injuries and no interventions were performed. One patient had a 
normal pancreatogram.  Ten patients required pancreatic surgery following ERP (distal 
pancreatectomy n=6, pancreaticojejenostomy n=3 and cystjejenostomy n=1). One 
patient unable to tolerate ERP had a distal pancreatectomy. 
 
Conclusion: 
The majority of ERPs were performed post surgery or after a delayed presentation.  
Diagnostic success was high and in conjunction with therapeutic interventions 77% of 
patients avoided surgery for their pancreatic complications. ERP is an effective tool in 















The incidence of pancreatic trauma is reported to be between 2-3% in patients with 
severe abdominal injury.1 This incidence is increasing due to a rise in high speed 
automobile accidents and an escalation in interpersonal violence involving dangerous 
weapons.2 In Western Europe, England and Australia the predominant cause of 
pancreatic injury is due to automobile accidents while in North American cities and 
South Africa penetrating injuries from gunshots are the most common.3-5 The likelihood 
of a pancreatic injury occurring is dependent on the mechanism of trauma. 
Approximately 5% of patients with blunt abdominal trauma have a pancreatic injury6, 
while 6% of patients with penetrating gunshot wounds7, and 2% of patients with 
penetrating abdominal stab wounds have a pancreatic injury.8 The pancreatic injury can 
occur as an isolated injury or as a component of an injury complex. 
 
Because of its rarity and subtle signs pancreatic injury may present diagnostic and 
therapeutic challenges to the surgeon.9 Pancreatic injury has a high morbidity of 
approximately 30%10 but this increases to 60% if diagnosis is delayed.6 The integrity of 
the pancreatic duct is the most important determinant of prognosis.9, 11-15 
 
Endoscopic retrograde pancreatography was first used in the management of patients 
with pancreatic injuries in 1976.16 Its use has evolved from a purely diagnostic 
procedure into a mainly therapeutic tool. This evolution has taken place during a period 
where cross-sectional imaging has become an integral part of the management of the 
trauma patient. Pancreatic complications are varied and the natural history is not well 
documented. The timing and role of ERP in pancreatic trauma is not clearly defined and 
treatment is done on an individual basis. There is consensus that the integrity of the 
main pancreatic duct is the key to assessing these injuries and the likelihood that they 
may complicate. ERP offers the ―gold standard‖ of ductal assessment and in some 













RELEVANT PANCREATIC ANATOMICAL CONSIDERATIONS  
 
The pancreas is a centrally placed retroperitoneal organ with numerous vital structures 
in close proximity. These are depicted schematically in figures 1 & 2. A pancreatic injury 
can be life threatening because of associated injuries to the liver, spleen, major blood 
vessels or hollow organs.  
 

























The pancreas is divided into 4 discrete areas (Figure 3). Contained within the C loop of 














Figure 3: Anatomical subdivisions of the pancreas. Line dividing body and tail is 
arbitrary. 17 
 
The ductal system of the pancreas comprises the main and accessory pancreatic ducts 
which lie anterior to the pancreatic blood vessels. The main duct of Wirsung arises in 
the tail and continues through the body at a level midway between the superior and 
inferior margins. Approximately 15 to 20 side branches enter the duct from the body and 
tail.  Within the head of the pancreas the duct courses inferiorly and posteriorly before 
entering the wall of the duodenum between the second and third part with the common 
bile duct entering superiorly, at the level of the second lumbar vertebra. The accessory 
pancreatic duct of Santorini has a variable drainage: either into the duodenum at the 
minor papilla or into the main pancreatic duct. This duct drains the anterior superior 





























Isolated injuries to the pancreas are uncommon.1 Due to the proximity of the pancreas 
to adjacent important structures most patients sustain multiple other significant injuries 
compounding the morbidity and mortality rate. In the 11 year single institution study by 
Vasquez et al. the associated injury rate in penetrating injury was 98%.8 Penetrating 
injuries are also more likely to be associated with multiple associated injuries than blunt 
injuries. An average of 2.619 to 3.68 associated injuries per patient have been reported. 
In penetrating trauma the most frequently injured organs are the liver (55%), stomach 
(51%), colon (24%) and duodenum (23%) compared to blunt trauma in which the liver 
(32%), spleen (28%) and duodenum (6%) are most likely to be injured.20 Blunt 
abdominal trauma can cause isolated pancreatic injury and presentation in these cases 
is often delayed.21 
 
GRADING OF PANCREATIC INJURIES 
 
Operative management of pancreatic injuries is based on the haemodynamic stability of 
the patient, associated injuries and grade of injury. Several grading systems exist and 
have been applied in the management of pancreatic trauma.  
 
The first of these was described in 1977 by Lucas22 in his paper on 















Table 1: Modified Lucas Classification of Pancreatic Injury 22, 23 
Class  Description  
I Simple superficial contusion or laceration with minimal parenchymal damage. 
Any portion of the pancreas can be affected but the main pancreatic duct is 
normal  
II Deep laceration, perforation or transection of the neck, body or tail with or 
without pancreatic duct injury 
III Severe crush, perforation or transection of the head of the pancreas with or 
without ductal injury 
IV Combined pancreaticoduodenal injuries, subdivided into: 
(a) minor pancreatic injury 
(b) severe pancreatic injury and duct disruption 
 
 
In 1990 the Organ Injury Scaling (O.I.S.) Committee of the American Association for the 
Surgery of Trauma (A.A.S.T.) published their grading system in the Journal of Trauma 
placing a greater emphasis on ductal integrity (Table 2).  
 
Table 2: Pancreas Organ Injury Scale of the American Association for the Surgery of 
Trauma (A.A.S.T.)24 
Grade  Injury  Description  
I Haematoma 
Laceration 
Minor contusion without ductal injury 
Superficial laceration without ductal injury 
II Haematoma 
Laceration 
Major contusion without ductal injury or tissue loss 
Major laceration without ductal injury or tissue loss 
III Laceration Distal transection or pancreatic parenchymal injury with ductal 
injury 
IV Laceration Proximal transection or pancreatic parenchymal injury 
involving the ampulla 













In this classification minor injuries (Grade I and II) have by definition an intact main 
pancreatic duct. These can be managed at operation by simple techniques (repair and 
drainage) while Grade III injuries and higher often require pancreatic resection.9 
 
Such is the importance of ductal integrity that in 2000 Takishima et al.25 proposed a 
classification of pancreatic injuries based on findings at endoscopic retrograde 
cholangiopancreatography and proposed a management algorithm based on these 
findings. 
 
Table 3: Classification of pancreatic injuries by endoscopic retrograde 
cholangiopancreatography25 
Grade Description 
I Normal main pancreatic duct on ERCP 
IIa Injury to branches of main pancreatic duct on ERCP with contrast 
extravasation inside the parenchyma 
IIb Injury to the branches of main pancreatic duct on ERCP with contrast 
extravasation into the retroperitoneal space 
IIIa Injury to the main pancreatic duct on ERCP at the body or tail of pancreas 
IIIb Injury to the main pancreatic duct on ERCP at the head of the pancreas 
 
The A.A.S.T. Pancreas Organ Injury Scale is the most widely used in the literature and 
not dependent on an ERP to grade the injury. This scale places emphasis on the ductal 
integrity of the pancreas whereas the Lucas classification does not emphasize this 
important factor. The majority of pancreatic injuries are minor and can be treated 
conservatively without the need for endoscopic grading thus the utility of Takashima’s 













DIFFICULTIES IN DIAGNOSIS 
The retroperitoneal location of the pancreas may mask presenting signs and symptoms. 
Isolated pancreatic injuries may present with few abnormal clinical findings and 
consequently early diagnosis may be difficult.21 In penetrating trauma associated 
injuries may mask an injury to the pancreas and even during laparotomy the pancreatic 
injury can be missed while focus is placed on major vascular injuries or intestinal 
spillage.11 
In all patients with abdominal trauma a high index of suspicion (starting with the
mechanism of injury) is necessary to make a prompt diagnosis. This is of particular 
importance in blunt trauma where the modern trend in management is towards non-
operative treatment. Clinical suspicion can be combined with laboratory and radiological
investigations to help ascertain the presence or absence of a pancreatic injury.
An increased serum amylase is neither sensitive nor specific for pancreatic injury and is 
also time (relative to injury) dependent. The reported incidence of hyperamylasaemia in
proven blunt pancreatic trauma ranges from 3% to 75%.1 Buccimazza et al.21 reported
on 16 cases of isolated main pancreatic duct injury and found the amylase level to be
raised in all patients. In those patients who presented acutely levels were >1000IU/L
while those with delayed presentation had a range from 200 to 490 IU/L.21 Other 
authors however have reported that even with complete transection of the main
pancreatic duct 38% of patients will have a normal serum amylase.20 However a
retrospective study by Takishima et al. evaluated amylase levels in 73 cases of blunt
pancreatic trauma and reported a raised level in 83%. All false negatives were in the
group which presented within 3 hours of injury.26 Therefore a delayed (>3 hours) or 
rising amylase level in conjunction with clinical signs of abdominal pain and tenderness 
is considered highly suspicious of pancreatic injury and further investigation with














Plain abdominal radiographs may show subtle signs which are suspicious of a 
pancreatic injury. If a duodenal injury is present there may be gas bubbles in the 
retroperitoneum or free intraperitoneal air. Fractures of the transverse processes are 
collateral evidence of a high energy injury and possible retroperitoneal trauma. 
Displacement of the transverse colon or stomach bubble and an overall "ground glass 
appearance" may also suggest pancreatic injury. A review article on the management of 
blunt abdominal trauma suggested that there was no role for routine plain abdominal 
films in patient assessment.27 In penetrating trauma however an erect chest radiograph 
is a useful investigation to identify free air under the diaphragm and to assess 
concomitant chest injuries. 
 
Ultrasound is now widely used in trauma units. The emphasis of FAST (Focused 
Abdominal Sonography in Trauma) is on detecting free fluid in the abdomen and has a 
sensitivity of 79 – 100% and a specificity of 95 – 100% in prospective observational 
studies. Directed examination of the pancreas is however often difficult due to overlying 
gas, associated abdominal injuries, obesity or subcutaneous emphysema. There is 
recent evidence in a Cochrane review and subsequent rebuttal study which both 
conclude that ultrasound directed management algorithms make no difference to patient 
outcome.28, 29 In patients with a delayed presentation and an abdominal mass 
ultrasound is a good investigation to confirm the presence of a possible pseudocyst. 
 
Computed tomography scan (CT) should intuitively be a more sensitive and specific test 
for pancreatic trauma. CT however tends to underestimate the grade of injury and when 
done in the acute setting may miss the pancreatic injury. In a multi-institutional review 
aimed at providing guidelines for the management of blunt pancreatic trauma CT had a 
sensitivity of only 71% in detecting unspecified pancreatic trauma and a sensitivity of 
only 43% in predicting a ductal injury.30 Although peripancreatic fluid, focal or diffuse 
pancreatic enlargement, and areas of low attenuation in the pancreatic parenchyma 











the pancreatic duct and may result in false positive and false negative diagnoses of 
main pancreatic duct disruption. This is despite newer CT technology which have 
reduced scanning times and improved resolution of 2D and 3D images. CT scans are 
more reliable in patients presenting late and with established pancreatic complications. 
Of the commonly available tests (amylase, lipase, ultrasound and CT) none is especially 
sensitive or specific for pancreatic ductal injury. However in combination an educated 
assessment can be made of the risk of pancreatic injury and the need to progress to 
further investigations. 
Magnetic resonance cholangiopancreatography (MRCP) is an accurate, quick (5
minutes) and non-invasive means of assessing the pancreatic duct. Fulcher et al.31
reported a series of 10 patients with suspected traumatic pancreatic injury where MRCP 
was used to guide clinical management. However the numbers were small and only 4
patients had evidence of a ductal injury.31 The expense of MRCP and a lack of
widespread availability has limited its application. Logistically its use in the acute setting
and in the multiply injured patient is difficult, although MRI compatible ventilators and
equipment have been developed.32
Dynamic secretin-enhanced MRCP is a newer modality available for identifying
pancreatic duct injury. This technique takes more time (20 min) than a standard MRCP 
and is similarly expensive and not widely available. It is very sensitive and specific and
an excellent non-invasive test for determining pancreatic duct integrity. In the largest
series utilizing this method the study population of 17 patients included 8 who had blunt
abdominal trauma. The seven patients who had an intact pancreatic duct on MRCP did
well on conservative treatment however three patients who had ―minor‖ ductal disruption
treated conservatively all developed persistent complications. 33 MRCP can be used to
screen for an intact duct but its role in assessing the severity of ductal injuries needs 
further clarification. Houben et al. reported 4 patients who had both MRCP and ERP for 
pancreatic trauma. In 3 patients the findings correlated however in one case the MRCP 












Currently ERP is the diagnostic tool of choice as it demonstrates contrast filling of the 
pancreatic ducts and extravasation in realtime.35 The place of MRCP in the diagnostic 
algorithm for pancreatic trauma is to assess pancreatic ductal integrity prior to an ERP, 
as the demonstration of an intact ductal system would reduce the number of non-
therapeutic ERPs, which is an invasive procedure with its own inherent complications. 
In a recent review article on ―ERP in pancreatic trauma: Need to break the mental 
barrier‖ MRCP was recommended for all patients with evidence of pancreatic injury on 
CT scan.11 
 
Table 4: Investigations used in the diagnosis of an injury to the pancreatic duct in 
patients with abdominal trauma11 
Investigation  Role in pancreatic trauma 
Serum lipase or amylase Low sensitivity and specificity. Elevated levels 
warrant further investigation 
Ultrasound abdomen Low sensitivity and specificity. Can provide 
supportive evidence by demonstrating free fluid. 
Diagnostic peritoneal lavage Not useful 
Contrast enhanced computed 
tomography 
Initial non-invasive investigation of choice. 
Indirect findings may suggest ductal injury. 
Excludes other solid organ injury reliably. 
Endoscopic retrograde 
pancreatography 
Most accurate method for detecting ductal 
injuries. Invasive and associated with 




Limited but encouraging experience. Non-
invasive. Therapeutic procedures not possible. 
Dynamic secretin-enhanced MRCP  Limited data suggest highly accurate in 
demonstrating pancreatic injuries. Non-invasive. 














OPERATIVE MANAGEMENT  
 
Pancreatic trauma can present in three forms.  
 
1) A patient with an acute indication for emergency surgery  
2) A stable patient with symptoms warranting further investigation 
3) Delayed presentation with epigastric pain and/or a  palpable mass  
 
In the acute setting focus is initially on the control of bleeding and contamination and on 
quantifying the associated injuries. Once these have been dealt with an adequate 
assessment needs to be made of the pancreas. Indicators of possible pancreatic 
trauma are a lesser sac fluid collection, haematoma over the pancreas, fat necrosis of 
the omentum or retroperitoneum and retroperitoneal bile staining.15 
 
Adequate mobilization of the pancreas is essential to make an accurate assessment of 
the injury. In the tail and body of the pancreas this may entail mobilizing the spleen to 
the midline to allow close inspection of the anterior and posterior portions of the 
pancreas. For injuries of the pancreatic head a full Kocherisation of the duodenum up to 
the third part allows adequate assessment. 
 
When inspecting the pancreas it is the integrity of the main pancreatic duct which is of 
paramount importance. Duct injury can either be seen directly within the injured 
pancreas or can be inferred from a major pancreatic laceration, penetrating central 
perforation or severely macerated pancreatic tissue.10, 15, 36, 37  
 
The initial management at laparotomy is determined by the grade of injury as assessed 
at operation. The American Association for the Surgery of Trauma guidelines (Table 5) 
are widely quoted but there are different approaches between institutions and individual 
surgeons. The Groote Schuur management policy is more conservative in terms of 
surgical undertaking when compared to the American Association for the Surgery of 












Table 5: Pancreatic trauma management options based on American Association for 
the Surgery of Trauma guidelines. 
Grade Treatment Options 
I Fix associated injuries 
Observation, drainage if needed (operative or percutaneous) 
II Fix associated injuries, ERP or MRP 
Observation, drainage if needed (operative or percutaneous) 
III Fix associated injuries 
Consider middle segment pancreatectomy, spleen preserving distal pancreatectomy, 
distal pancreatectomy 
Drainage suggested, consider pancreatic sphincterotomy 
IV Fix associated injuries 
Consider middle segment pancreatectomy, Roux-en-Y to disrupted region, pyloric 
exclusion, duodenal diverticulization 
Extensive drainage suggested, consider pancreatic sphincterotomy 
V Fix associated injuries 
Consider middle segment pancreatectomy, Roux-en-Y to disrupted region, pyloric 
exclusion, duodenal diverticulization, rarely pancreaticoduodenectomy 
Extensive drainage suggested, consider pancreatic sphincterotomy 
 
Grade I and II injuries should be treated with haemostasis and drainage. Primary repair 
was initially thought to reduce the complication rate3 however other studies have refuted 
this and these injuries can be treated conservatively.10, 39, 40  
 
Grade III injuries should be treated by distal pancreatectomy and splenectomy. In the 
haemodynamically stable patient a splenic preserving distal pancreatectomy may be 
considered. Some authors advocate saving more pancreatic tissue by constructing a 
pancreaticogastrostomy or a pancreaticojejunostomy.41   
 
Grade IV injuries should be treated by external drainage and monitored closely for 
development of complications. Complicated procedures such as anastomosing a Roux-












probably higher than the natural risk of a pancreatic fistula. Adequate drainage is the 
preferred surgical treatment of these injuries.42 
 
Grade V injuries are by definition ―a massive disruption of pancreatic head and 
duodenum.‖ Good outcomes with these injuries also follow the tenets of other 
pancreatic injuries: the simpler the better. Primary duodenal repair and adequate 
external drainage is the optimum strategy. Some authors recommend pyloric exclusion 
(gastrojejunostomy and pyloric closure from within with a slowly absorbable suture) to 
reduce the complication rate. Using this technique Feliciano et al. reported a pancreatic 
fistula rate of 26% and a duodenal fistula rate of 6.5%.43  Despite this high complication 
rate many authors still recommend this treatment for combined pancreaticoduodenal 
injuries.9,43 
 
Only when simpler measures are not at all possible should a Whipple’s resection be 
contemplated. In the trauma setting this is usually done as a two stage procedure: the 
first being a damage control laparotomy and within 48 hours the definitive operation.44 
 
In stable patients with a possible isolated pancreatic injury there is no role for surgery 
acutely. Further steps to define a possible ductal disruption need to be taken based on 
symptoms and investigations. 
 
PANCREATIC COMPLICATIONS - OVERVIEW 
 
The propensity for pancreatic injuries complicate is well known. Inappropriate initial 
management of pancreatic injury leads to a higher rate of pancreatic morbidity and 
mortality.6  Increasing non-operative management strategies for abdominal trauma 
mean that the clinician must be aware of the possibility of an occult pancreatic injury in 
order to avoid complications.  These complications can occur following delay in 
treatment, after conservative non-operative management or after operative intervention. 
They are related to leakage of pancreatic ductal secretions, infection and stricture 












pseudocyst, stricture, abscess, and ascites. Pancreatic complications may evolve from 
one into another and may occur in combination.  
 
The terminology to describe common pancreatic complications is largely derived from 
the Atlanta classification. In 1992 this consensus meeting defined pancreatitis and more 
clearly defined the terminology relating to the local complications of pancreatitis.30 The 
focus was on pancreatitis due to gallstones or alcohol and not traumatic pancreatic 
injury however its definitions are widely accepted.  
 
The local pancreatic complications defined are: 
(i) Acute fluid collections occur early in the course of acute pancreatitis, are 
located in or near the pancreas, and always lack a wall of granulation or 
fibrous tissue. 
(ii) A pseudocyst is a collection of pancreatic juice enclosed by a wall of fibrous 
or granulation tissue (>4 weeks old). 
(iii) A pancreatic abscess is a circumscribed intra-abdominal collection of pus, 
containing little or no pancreatic necrosis. 
(iv) Pancreatic necrosis is a diffuse or focal area of non-viable pancreatic 
parenchyma. 
 
Despite the publication of the Atlanta classification there are still marked variations in 
terminology between studies. In a review article containing 12 guidelines and 82 review 
articles, altered definitions of predicted severity of acute pancreatitis, actual severity, 
and organ failure were used in over half of the studies. The authors noted a large 
variation in the interpretation of the Atlanta definitions of local complications, especially 
relating to the content of peripancreatic collections.45 The Atlanta classification does not 
define pancreatic fistulae (see later section on pancreatic fistulae) or pancreatic ascites. 
 
While the natural history of traumatic pancreatic complications is not described as a 
separate entity in the literature, using recognized terms from the pancreatitis literature 











INCIDENCE OF PANCREATIC COMPLICATIONS 
The complication rate following pancreatic trauma is notoriously high. 









Cogbill, 198246 38 34 5 
Jones, 198547 450 8 3 
Smego, 198539 57 19 3 
Mansour, 198948* 79 35 17 
Wisner, 199049 85 25 0 
Ivatury, 199050 76 29 8 
Cogbill, 199151 75 45 3 
Akhrass, 199713 72 29 0 
Patton, 199710 123 31 2 
*The mortality rate is much higher in combined pancreaticoduodenal injuries as reported
by Mansour et al., the obvious outlier in the above table, who reported a 17% mortality












AVOIDANCE OF COMPLICATIONS 
 
The principles of management of pancreatic trauma focus on the need for early 
diagnosis and accurate definition of site and grade of the injury in order to facilitate 
optimal intervention. Delays can result in serious complications.  
 
SPECIFIC COMPLICATIONS - PANCREATIC FISTULA 
 
There are a variety of definitions of pancreatic fistulae based on the fistula volume, 
duration, amylase content, and route. This has resulted in marked variations in the 
reported incidence of pancreatic fistulae in the literature. An international study group 
paper defined a pancreaticocutaneous fistula as a drain output of any measureable 
volume after post-operative day 3 with an amylase content greater than three times the 
serum amylase level.52 This communication between the disrupted pancreatic duct and 
the skin causes significant morbidity due to malnutrition, skin excoriation and infection. 
 
The majority of literature dealing with pancreatic fistulae relates to elective surgery or 
pancreatitis, and not primarily to traumatic injury of the pancreas. In a review article by 
Alexakis et al. the incidence of pancreaticocutaneous fistulae is reported at 12 – 13%.  
53 Fistula rates are however similar whether the pancreatic trauma is accidental or by 
design (Table 7).  
 
Table 7: Incidence of pancreatic fistulae following pancreaticoduodenectomy, distal 
pancreatectomy and pancreatic trauma.53 
Cause Total No. of 
patients 
No. of fistulae Fistula rate 
(%) 
Pancreaticoduodenectomy 3268 422 12.9 
Distal pancreatectomy 617 80 13 













Various other types of pancreatic fistulae can occur. Internal fistulae can occur between 
the pancreatic duct and the bowel, the peritoneum, or the pleural cavity. 
Pancreaticobronchial, pancreaticomediastinal and pancreaticopericardial fistulae have 
also been described but are extremely rare and are more commonly associated with 
chronic pancreatitis.54 
 
Imaging of fistulae can be done by fistulography, CT scan, magnetic resonance 
cholangiopancreatography (MRCP), and endoscopic retrograde pancreatography 
(ERP). CT scan or MRI may give valuable information on associated injuries and 
degree of parenchymal damage which may influence management. ERP is the gold 
standard in delineating pancreatic fistulae. ERP demonstrates filling of the pancreatic 
ducts and extravasation of contrast in real time. Fluid collections can be shown to fill 
from the pancreatic duct. The degree of disruption of the pancreatic duct can be 
assessed as a side branch extravasation, a minor main duct leak (with continuity of the 
main duct distally), or a major main duct leak (with complete disruption/cut-off). ERP 
also offers therapeutic options at the same procedure. 
 
There is no universally accepted prevention strategy to reduce the incidence of 
pancreatic fistulae. Somatostatin and its analogues (octreotide) have not been shown to 
have an effect following pancreatic surgery in a large meta-analysis.55 The benefit of 
fibrin glue at surgery is also not proven.56, 57 
 
Treatment options for pancreatic fistulae are conservative, endoscopic or surgical. An 
initial conservative approach to pancreatic fistulae is justified in that 80% of fistulae will 
close with appropriate nutrition, control of sepsis, correction of fluid and electrolytes, 
and adequate skin care. However the duration of hospital stay is often prolonged and 
currently there is no method to determine which patients will benefit from early 
endoscopic intervention to facilitate earlier resolution of their fistula.58 
 
Miller et al. and Prinz et al. used a classification scheme based on the pancreatic duct 












fistula being is when the main pancreatic duct opacifies beyond the leak site.59, 60 In a 
recent series discussing the contemporary treatment strategies for pancreatic fistulae 
following surgery none of the patients with ―end fistulae‖ healed with conservative 
treatment.61 Thus assessment of the pancreatic duct integrity can help to select those 
patients who are unlikely to respond to conservative treatment. In centres with the 
necessary expertise there is a trend towards earlier endoscopic assessment and 
intervention for pancreatic fistulae secondary to pancreatitis (acute or chronic) instead 
of a long-term conservative approach.62  
 
Opacifying the pancreatic duct is not without risk and a high injection pressure is a 
known risk factor for post ERCP pancreatitis. Even with adequate contrast up to 10% of 
fistulae may not be evident on ERP (although this was a study f pancreatitis 
patients.)63 In these patients with a fistula confirmed by other means a trial of pancreatic 
sphincterotomy (and possibly stent placement) is still warranted to favour physiological 
drainage and hasten fistula closure.  
 
The aim of endoscopic therapy is to reduce the pancreatic duct pressure by pancreatic 
sphincterotomy, stent placement or nasopancreatic drain. Stenting beyond the defect 
also results in increased resolution of fistulae. Up to 90% of patients with pancreatic 
fistulae can be successfully treated endoscopically.62 The optimum length of stenting is 
not known and the stent itself may lead to ductal epithelial damage and subsequent 
stricturing. In previous healthy pancreatic ducts these strictures are rarely clinically 
significant and often disappear on follow-up.62, 63 Canty et al.64 removed two patients’ 
stents under weeks after placement and still noted some clinically insignificant ductal 
changes in one patient. Stents are often left in for up to 2 months in endoscopic 
treatment of post-surgical pancreatic fistulae and even longer in chronic pancreatitis 
patients. Halttunen et al.62 advised that stents be removed as soon as feasible. 
 
The final treatment option for pancreatic fistulae is surgery. However a trial of 
endoscopic treatment is warranted in most patients given the morbidity and mortality 












occurring in the head of the pancreas where pancreaticoduodenectomy has significant 
morbidity and mortality and endoscopic access is relatively good. Resectional surgery of 
the tail of the pancreas is less technically demanding and endoscopic access quite 
challenging in terms of stenting. Thus while a trial of endoscopic therapy is warranted in 
most patients the location of the defect will influence persistence with such therapy 
before proceeding to surgery. Pancreatic tail resection has been the preferred treatment 
option for trauma patients.62   
 
SPECIFIC COMPLICATIONS - PANCREATIC PSEUDOCYST 
 
A pancreatic pseudocyst is defined as a pancreatic fluid collection more than 4 weeks 
old and surrounded by a wall of fibrous or granulation tissue. Pseudocysts may vary 
markedly in their symptomatology, size, wall thickness, location, content and whether 
they are single or multiple. 
 
Methods of classifying pseudocysts have been proposed by D’Egido and Bornman in 
separate papers.65, 66 Three distinct types of pseudocysts were identified in chronic 
pancreatitis patients, with the message extrapolated to pancreatic trauma being that 
management differs based on the status of the main pancreatic duct. Pseudocysts may 
occur following minor duct disruption or parenchymal injury and have normal major 
pancreatic duct anatomy with no demonstrable communication between the pancreatic 
duct and the cyst. Alternatively there may be a main pancreatic duct disruption and 
hence a significant incidence of duct-pseudocyst communication. 
 
Initial treatment of uncomplicated pseudocysts with minimal symptoms is ―watchful 
waiting‖ as 40% will resolve without intervention.67 Of those pseudocysts persisting for 
longer than 6 weeks the need for intervention was based on the fact that these rarely 
resolved and had a 50% complication rate.68 However in more recent studies 
conservative treatment showed a more indolent course with the authors advocating a 
less interventional approach – although neither of these studies looked at endoscopic 













In evaluating a pseudocyst it is important to consider alternative diagnoses such as a 
cystic pancreatic neoplasm. In the trauma setting this is unlikely and if there are no 
concerning features such as septations or associated inflammatory changes on CT 
scanning it is safe to treat these patients as traumatic pseudocysts. CT scanning also 
allows the content of the pseudocyst to be evaluated. The amount of necrotic pancreatic 
debris may necessitate repeat interventions for effective drainage. Incomplete drainage 
can lead to recurrent sepsis and incomplete symptom resolution. 
 
For endoscopic transmural drainage the wall of the pseudocyst should be well formed 
and this typically occurs after 4 – 6 weeks. The wall should be in close apposition to the 
stomach or duodenum. This is assessed on CT scan and by the presence of a bulge at 
endoscopy. EUS offers further assistance in assessing apposition when there is no 
bulge and can help avoid blood vessels in the potential drainage site. Clear benefit of 
one method over the other has not been demonstrated and local expertise and the 
individual patient presentation should determine treatment.71 
 
A pseudocyst complicate with a pseudoaneurysm and this represents a contraindication 
to endoscopic treatment, unless prior embolization has been successful. 
Gastrointestinal bleeding, sudden pseudocyst expansion and an unexplained drop in 
haemotocrit are suggestive of a pseudoaneurysm. The presence of pseudoaneurysm 
can be assessed on the arterial phase of a CT scan. 
 
Optimal treatment is achieved by effective drainage of the pseudocyst.72 Some authors 
take the view that simple drainage of the pseudocyst is sufficient and the inherent status 
of the duct need not be known. However the risk of recurrent pseudocyst, pancreatic 
fistula or downstream chronic pancreatitis from a stricture, remains if there is not a 
permanent drainage route for residual pancreatic parenchyma.73  
 
Treatment options are percutaneous, endoscopic or surgical. These need to be 











Percutaneous techniques are easily available, are safe in sick, multiply injured patients 
and offer effective drainage with the option of repeated flushing of the drain if there is a
concern of sepsis. This treatment can be definitive in patients where the pancreatic duct
does not communicate with the pseudocyst. However in patients with persistent
communication and possible downstream stricturing there is a high rate of recurrence or 
formation of a pancreatic fistula. In the paediatric literature a paper reported on two
children who had non-operative management of traumatic pancreatic pseudocysts with
associated pancreatic duct injury. After percutaneous drainage the pancreatic 
complications only resolved after 45 days to 2 months, with the use of TPN and
octreotide infusion in one patient.74 It must be noted however that these ―pseudocysts‖ 
would be defined as acute fluid collections by the Atlanta classification.
Endoscopic drainage offers successful drainage in 82-89% of pseudocysts, has a
complication rate (of bleeding) requiring surgical intervention in 5% and has a
recurrence rate of 6 – 18% with up to 4 years follow-up.75 In a series of 37 patients 
looking specifically at endoscopic efficacy the procedure was technically possible in
92% of patients. The reported morbidity was 16%, with no deaths and endoscopic 
drainage was a definitive treatment in 65%.76 The majority of the literature deals with
pseudocysts as a complication of pancreatitis with few reports dealing with pseudocyst
drainage following abdominal trauma.
Lin et al.77 reported on 9 patients with a pseudocyst following blunt trauma. They
concluded that percutaneous drainage should be considered the primary therapy when
there is no major pancreatic duct injury and the injury is distal. Only if there is no
resolution do they advise an ERP to prove a proximal duct injury. If ERP demonstrates 
a disrupted but not obstructed duct then pancreatic stenting may avert surgical
resection. However if there was obstruction/complete cut-off then the authors felt
surgical resection was required. Two of their patients had ERP and pancreatic duct
stenting in the acute setting. Despite successful stenting these patients went on to
develop ―pseudocysts‖ noted on days 7 to 20 following the injury. By the Atlanta












would explain why, in this study published in 2006, there were no endoscopic 
cystenterostomies of the ―pseudocysts‖. The wall of granulation tissue would not have 
been sufficiently formed to allow safe endoscopic drainage. 
 
Buccimaza et al.21 reported six patients in their series of isolated main pancreatic duct 
injuries who presented (after a delay from their injury) with an epigastric mass defined 
as a pancreatic pseudocyst on subsequent CT scan. ERP was able to accurately locate 
the ductal injury by cut-off or extravasation in all patients. Various endoscopic 












Table 8: Traumatic pancreatic pseudocyst: endoscopic technique and result. 21 
Endoscopic technique Treatment 
Percutaneous transgastric endoscopically assisted gastro-
pancreatic cyst stent decompression. 
Successful  
ERP needle knife pancreatico-cyst gastrostomy with 
subsequent endoscopic tract dilatation 2 weeks later. 
Successful 
ERP gastro-pancreatic cyst stent decompression with cyst 
resolution and subsequent stent removal. 
Successful 
ERP gastro-pancreatic cyst stent decompression with stent 
migration 
Failed – subsequent 
distal pancreatectomy 
ERP gastro-pancreatic cyst stent decompression with stent 
migration 
Failed – subsequent 
pancreaticojejenostomy 
ERP gastro-pancreatic cyst stent decompression. Successful 
 
Open surgery is considered the gold standard of pseudocyst treatment due to a low 
recurrence rate of 5%. However surgery does carry a significant morbidity and 
mortality.78 Surgical procedures aim to drain the pseudocyst via cystgastrostomy or 
cystenterostomy. These procedures have also been described laparoscopically.79  The 
use of surgery has been tempered by the widespread increase in the use of endoscopic 
techniques. Endoscopic drainage has a low complication rate, is very effective and 
should be attempted in all patients in whom it is feasible with surgery reserved for those 
patients in whom endoscopic drainage fails.  
 
SPECIFIC COMPLICATIONS - PANCREATIC STRICTURE 
 
Pancreatic trauma can cause various degrees of duct disruption and subsequent 
healing can result in stricture formation. The injury can vary from a slight narrowing of 














Various management algorithms have been proposed for ductal disruptions. In all cases 
the clinical situation must be adequately assessed. Minor disruptions may heal with 
conservative treatment. Decompression of the pancreatic ductal system to promote 
normal flow and drainage of pancreatic juices into the duodenum can be done by a 
pancreatic sphincterotomy. Dilatation and stenting of strictures further aids this process. 
 
The technique of endoscopic stenting varies between centres and must be adapted to 
the locations and severity of the pancreatic injury. When possible a stent placed across 
a defect is preferable however this may be technically impossible particularly if the injury 
is complete or distal. When unable to bridge the defect the stent can be left into the 
collection or up to the defect. Failing this a short trans-sphincteric stent or 
sphincterotomy alone can be used in an attempt to decompress the pancreatic ductal 
system. 
 
The success rate of such endoscopic therapy is not known as there are no large 
studies. Rather patients proceed directly to surgery based on the degree of duct 
disruption at ERP and endoscopic intervention is not attempted or reattempted.  
 
COMPLICATIONS OF ENDOSCOPIC RETROGRADE PANCREATOGRAPHY  
 
ERP is not a benign procedure. It is invasive, requires sedation and is prone to various 
complications. The major complications associated with ERP are pancreatitis, bleeding, 
perforation and sepsis. Other events are rare but may be equally life threatening and 
include cardiopulmonary and sedation-related complications, contrast allergy and distal 
embolism, systemically or into the portal system. 
 
It should be noted that all the major review articles do not distinguish between 
endoscopic biliary interventions and endoscopic pancreatic interventions. It is however 
noted that an endoscopic retrograde cholangiogram (ERC) in a blocked biliary system is 
more likely to result in post ERC sepsis and that imaging the pancreatic system with 












Post ERP pancreatitis is the most common complication of ERCP. A transient increase 
in serum amylase post ERCP is found in up to 75% of patients. Acute clinical 
pancreatitis - hyperamylasaemia combined with abdominal pain requiring hospitalization 
is uncommon. The overall incidence is reported at 3% in most studies. 
 
Post ERP bleeding is a relatively uncommon complication and is most commonly 
observed after sphincterotomy. Patients with a bleeding diathesis and those with 
unfavourable anatomy are most at risk and require periprocedural optimisation. The 
incidence in a large review article of 21 studies found a bleeding rate of 1.3%, 226 of 
16,855 patients, with eight deaths (0.05%) related to bleeding.80 The length of 
sphincterotomy is accepted as a risk factor for bleeding and should never be longer 
than necessary. The experience of the endoscopist and his or her case volume is a risk 
factor as is the use of a needle-knife sphincterotomy or a rapid ―zipper cut‖. Bleeding 
can typically be dealt with by injection sclerotherapy, followed by electrocautery or 
clipping of visible vessels. Refractory bleeding may need angiographic embolization or 
even surgery. Catastrophic bleeding can occur when draining a pseudocyst. A 
pseudoaneurysm should be embolised prior to drainage. EUS guidance is advised for 
patients with evidence of segmental portal hypertension to reduce the risk of hitting 













ANALYSIS OF PREVIOUS STUDIES LOOKING AT PANCREATIC TRAUMA AND 
ENDOSCOPIC RETROGRADE PANCREATOGRAPHY  
 
Endoscopic retrograde cholangiopancreatography in pancreatic trauma81 
 
In 1988 Barkin et al. opened their article with the statement: ―Pancreatic ductal rupture 
can be an elusive diagnosis.‖ Early studies of ERP in pancreatic trauma focused entirely 
on the diagnostic utility of ERP with no interventions being performed. The authors 
reported on 14 consecutive patients with abdominal pain and a suspected pancreatic 
injury secondary to trauma who underwent ERP. ERP was 100% sensitive and specific 
for pancreatic ductal rupture while no combination of serum amylase, CT scan and 
peritoneal lavage was as effective.   
 
Blunt Pancreatic Trauma: Prospective Evaluation of Early Endoscopic Retrograde 
Pancreatography82 
 
In this study from the University of Miami, Whittwell et al. reported on nine patients with 
suspected pancreatic injury who underwent ERP. Eight were technically successful. 
Two patients with major ductal injury were treated operatively while 6 patients with 
normal ducts were treated conservatively. The authors concluded that ERP was safe 
and accurate in assessing the pancreatic ductal system and in guiding management. 
 
Contribution of endoscopic retrograde pancreatography in the management of 
complications following distal pancreatic trauma83 
 
This study by Wind et al. demonstrates the natural history of pancreatic complications 
following trauma. Thirty-eight patients with distal pancreatic trauma developed 
complications, 16 fistulae and 12 pseudocysts. In 16 patients ERCP was used to 
determine management. Two patients with a side duct disruption had pancreatic fistulae 
which settled after 17 and 21 days respectively. One patient with a pseudocyst and an 












pancreatic resection based on the finding of complete ductal disruption at ERCP. Two 
patients with indications for acute laparotomy had ERCP assessment prior to surgery. 
One patient demonstrated ductal disruption and had an uncomplicated splenic 
preserving distal pancreatectomy. The other, with an intact pancreatic duct on ERP, had 
a drain placed to the pancreas at laparotomy and recovered uneventfully. The delay to 
ERCP (excluding two preoperative ERCPs) was 14 days to 4 years post injury. 
Nineteen patients had a main pancreatic duct (MPD) injury treated without initial 
resection. Fourteen patients developed fistulae with 4 healing spontaneously and 10 
requiring surgery (7 for persistent fistulae, 2 for subsequent pseudocyst development 
and 1 for chronic pain). The remaining five patients with MPD injury developed 
pseudocysts ultimately requiring surgery.   
 
This study shows that the integrity of the pancreatic duct is integral to the development 
of pancreatic complications. When demonstrated to be intact or with only a minor side 
leak non-operative management was successful – both for fistulae and pseudocysts. 
Persistent pancreatic complications generally had major ductal disruption at ERCP and 
required surgery. 
 
The role of endoscopic retrograde pancreatography in the treatment of traumatic 
pancreatic duct injury84 
 
In 2001 Kim et al. reported on 23 patients undergoing ERP, with 14 patients having 
pancreatic duct injuries demonstrated. CT scan was used in 11 patients with main 
pancreatic duct (MPD) injury being successfully predicted in 6 patients. In 3 patients 
pancreatic injury was suspected but not accurately graded. In two patients a MPD injury 
was falsely predicted. At ERP 3 of the pancreatic duct injuries were side branch leaks 
into pancreatic parenchyma which settled on conservative treatment. Of the 11 MPD 
injuries 8 showed leakage into the peritoneum and were explored surgically. Five 
patients had distal pancreatic resection, one had a pancreaticoduodenectomy and the 
remaining two had simple surgical drainage due to severe adhesions (both had a 











extravasation limited to pancreatic parenchyma were successfully treated by 
endoscopic stent insertion. The stents were left in situ for 3 months and in 2 patients 
asymptomatic stricturing was noted. 
The authors analysed their data based on delay to ERP and its relationship to
pancreatic complications. The 9 patients who had early ERP were compared to the 5
who had an ERP after 72 hours. There was a 100% complication in the late group
compared to 22% in the early group. The authors concluded that early ERP reduced the
complication rate. It must be noted that numbers were small and despite these
complications the length of hospital stay between the two groups was not statistically
significant.
An ERP in the acute setting was feasible and useful in guiding treatment. The authors 
also concluded that the AAST grading of pancreatic injuries be refined to include the
degree of pancreatic duct disruption.
Treatment of pancreatic duct disruption in children by an endoscopically placed
stent64
Also in 2001 Canty and Weinman from San Diego treated two children with traumatic 
pancreatic duct disruption endoscopically. In one patient the stent was passed across 
the site of injury while in the other this was unsuccessful and a simple transampullary
stent was left in place. The stents were removed very early at 11 and 12 days 
respectively. In one patient a stricture was noted at the injury site on follow-up ERP.
This was dilated and although an incidental pseudocyst was noted on follow-up CT scan
(which subsequently resolved) no further treatment was necessary.
These patients had intense follow-up and if one looks hard enough minor pancreatic 
abnormalities may be evident however the clinical significance is debateable. The two 
children had AAST Grade II and III injuries with a ―side hole‖ injury in an otherwise intact












disruptions however the natural history of these minor disruptions is good even when 
left alone. 
 
The value of endoscopic diagnosis and the treatment of pancreas injuries 
following blunt abdominal trauma85 
 
Wolf et al. from Germany reported on 5 patients with suspected pancreatic injury 
undergoing ERP. Only 2 patients had ductal disruption at ERP. One was after a 
laparotomy and pancreatic resection while the other was initially treated non-
operatively. Both leaks were successfully treated by endoscopic stenting. Stents were 
removed after 16 days in one patient and 3 months in the other.  
 
The rarity of the injury is illustrated as the study was carried out over 5 years. If no 
ductal disruption was found patients did not develop pancreatic complications. 
 
Long-term results of endoscopic stent in the management of blunt major 
pancreatic duct injury86 
 
In 2006 Lin et al. reported on the long-term follow-up of patients treated with stenting of 
major pancreatic duct disruption and showed less favourable results than other studies. 
One patient died 3 days post stent insertion due to multi-organ failure. The remaining 
five patients all had stent related complications with multiple reinterventions. 
 
One patient underwent 15 ERPs related to stent changes with the average patient 
having eight ERPs. The average duration of treatment was 25 months. The authors 
concluded that stenting could avoid surgery but given the ―inevitability of stricturing‖ 














Treating main pancreatic duct injuries with stenting is not a single intervention and 
multiple reinterventions are common. Protracted endoscopic therapy may not be 
preferable to surgery for some patients.  
 
Isolated main pancreatic duct injuries spectrum and management21 
 
From Durban, South Africa this retrospective review by Buccimazza et al. in 2006 of 16 
patients (14 blunt and 2 penetrating) divided patients into acute and chronic 
presentations. The acute patients all proceeded to surgery based on an acute abdomen 
in three and CT evidence of pancreatic injury in six. The operations performed were six 
splenic-preserving distal pancreatectomies, one suture repair and drainage, one 
pancreaticogastrostomy and one pancreaticojejenostomy. None of these patients 
underwent ERP. In the delayed presentation group (from 2 weeks to 6 months post 
injury) six patients presented with an epigastric mass shown to be a pseudocyst and 
one patient presented with sepsis. The patient with sepsis died after three days 
following an attempted necrosectomy. ERP was used in 6 patients with delayed 
presentation and endoscopic intervention successful in 4. 
 
Traumatic pancreatic duct injury in children: minimally invasive approach to 
management.34 
 
Houben et al. from Kings College Hospital, London reviewed a minimally invasive 
management approach in 15 children admitted with pancreatic trauma. A significant 
delay was noted in 13 due to minimal presenting symptoms. 
 
Eleven children had a CT scan and an ERP. CT was reported to accurately identify the 
pancreatic injury in 10 patients although the authors do not report whether it was able to 
accurately grade the pancreatic ductal injury. In one case with a normal CT subsequent 
ERP demonstrated a Grade IV injury. The higher pick-up rate of pancreatic injury 
compared to other studies was attributed to the delay in presentation. CT features of 












children with 4 going on to have an ERP.  Of the three who were treated conservatively 
following MRCP two had minor ductal injuries demonstrated, but due to minor clinical 
symptoms ERP was withheld. These two patients and the other patient had no ductal 
disruption demonstrated all did well with no further intervention. 
 
In patients with both an MRCP and an ERP the non-invasive test was 100% sensitive. 
By using an MRCP in patients with a clinical suspicion of pancreatic duct injury (based 
on CT or clinical suspicion) three patients were spared unnecessary ERPs. The reason 
that MRCP wasn’t more widely used during this study was that it only became available 
during the latter years of the study.  
 
Of the twelve children undergoing ERP nine had endoscopic stent placement: three 
across the ductal defect and six into the fluid collection at the site of ductal disruption. 
There were two technical failures to place a stent: due to a tortuous duct in one and a 
pancreatic divisum in another. 
 
Three stents were exchanged for larger stents (5-7 French) to allow better drainage of 
residual collections and in one patient a blocked stent was replaced after 4 months. All 
stents were removed at a median of 127 days (range 56 – 193 days). Two patients had 
mild self-limiting pancreatitis following stent insertion.  
 
Two patients had endoscopic cyst-gastrostomy drainage of pseudocysts (on days 38 
and 41 respectively). One of these proceeded to surgery when the pseudocyst recurred 
8 weeks after removal of the internal drain. Eleven of the children were treated with 
parenteral nutrition for a median of 28 days (range 11 – 50) and the total hospital stay 
was for a median of 41 days. (range 15 – 67) Despite successful endoscopic treatment 
the patients were in hospital for a protracted period of time due to this cautious 
approach to oral feeding. The authors did not report any pancreatic strictures in their 













Blunt pancreatic trauma and pseudocyst: Management of major pancreatic duct 
injury77 
 
Lin et al. reported the long term outcome of children with endoscopic drainage of their 
pseudocysts as very good in 2007. There were no recurrences in nine patients (8 due to 
trauma). In two patients with assessment of their pancreatic duct there was complete 
cut-off with no communication into the pseudocyst.  
 
Endoscopic retrograde cholangiopancreatography in patients with pancreatic 
trauma87 
 
In 2010 Rogers et al. from San Francisco published the largest series in the literature 
consisting of twenty-six patients accumulated over 13 years.  Nine injuries were 
penetrating 16 blunt with 1 being a complication following a total colectomy. Over half 
(54%) underwent emergency laparotomy on admission. Forty-six percent were initially 
treated non-operatively and had further diagnostic work-up. The entire study group 
underwent ERP at some stage during their admission.  The indication for ERP was if 
serum amylase, lipase, CT scan or laparotomy findings suggested a pancreatic injury. 
Five were carried out on the day of injury, 2 prior to laparotomy, 1 during laparotomy 
and 2 after abdominal closure.  
 
Eight patients (31%) had a negative ERP with one patient being diagnosed with an 
unsuspected gallbladder rupture. A total of eighteen patients (69%) were found to have 
pancreatic duct injury. Endoscopic interventions included five sphincterotomies, one had 
a nasopancreatic drain, and six had pancreatic duct stent placements (7 – French). All 
stents were removed 4-8 weeks after placement and all patients demonstrated a healed 
MPD. Stricturing was not reported. Nine patients were discharged without further 
surgical treatment following endoscopic intervention.  Follow-up at 6 – 24 months 













Three patients, including one patient with a stent placed, were taken to theatre for a 
distal pancreatectomy and splenectomy based on the ERP findings. Six patients had 
minor injuries not requiring intervention. One of these patients went on to develop a 
pseudocyst which was treated operatively with a pancreatic cystgastrostomy. Fifteen of 
the patients with proven ductal injury received an octreotide infusion for an unspecified 
amount of time.  
 
This series shows that endoscopic intervention can be successful in guiding operative 
management, and as a therapeutic modality can potentially reduce the need for further 
surgery. The negative ERP rate of 31% shows a low threshold for this investigation and 
the role of MRCP to reduce this rate needs to be explored. The number of patients 
spared an ERP would be even higher if MRCP could successfully assess the minor 
injuries picked up on ERP which were treated conservatively. The duration of follow-up 
of these patients was variable as is typical for trauma patients.  
 
Operative vs. nonoperative management of blunt pancreatic trauma88 
 
Also in 2010 Wood et al. from Colorado, USA noted a lack of management protocols for 
pancreatic trauma in children with debate being between operative and non-operative 
management strategies. Their study took 11 years to accrue 43 patients. Fifteen 
patients underwent ERP 12 of which were technically successful.  
 
All patients with positive ERP findings had evidence of pancreatic injury on CT scan 
however it wasn’t mentioned whether this was under or over-assessed except that 3 
patients with Grade I injuries were found to have no injury, 2 at laparotomy and 1 at 
ERP. 
 
The major conclusion was that non-operative management of pancreatic injuries carries 
a significantly higher risk of complications than operative intervention (73% vs. 21%, 
p=0.02). This did not however translate into increased hospital stay or readmission 











IV injury. Six patients with major main duct disruption were managed operatively while 6 
patients were managed non-operatively: Four main duct injuries without complete 
transection and 2 with side branch injuries. 
Despite an ERP assessment the authors noted an increased pancreatic complication
rate in the non-operatively treated patients. (86% vs. 29%, p=0.02) They did not specify
the location of the MPD injury or the details of the complications. Of 6 patients treated
conservatively post ERP only one had a successful stent placement. It was not reported
whether a sphincterotomy was performed at ERP in the other 5 patients. Whether 
routine sphincterotomy offers a benefit in reducing complications in these patients is 
debateable. This study highlights the technical difficulties of endoscopic treatment and
the importance of reporting specific details regarding the nature of the injury and the
form of the complications in order to adequately assess treatment.
Summary of previous studies looking at pancreatic trauma and endoscopic 
retrograde pancreatography 
There is an evolution in the role of ERP in the literature with time. ERP was initially used
in a purely diagnostic role with the status of the main pancreatic duct used to decide on 
whether surgery was required. 81-83 With the availability of endoscopic stenting various 
authors attempted stenting of the pancreatic duct in an effort to prevent or treat
complications. 34,64,72,84-88 
The success of endoscopic interventions depends on various factors and can be difficult 
to assess. Various authors have reported the success of endoscopic stenting. However 
the injuries are sometimes minor, and with the natural history of pancreatic injuries 
being poorly documented assessing these interventions is difficult.  The timing of the 
endoscopic intervention is a further consideration. However ERP is rarely performed 













Technical success rates of ERP depend on the intention to treat. When limited to purely 
diagnostic imaging there have been 4 reported failures in visualising the pancreatic 
duct.64,77,88 The technical success rate of stenting is difficult to assess however when 
the surrogate marker of success is the avoidance of surgery there are still 31 patients 
across 6 studies who ultimately required surgery even in the era of interventional 
ERP.34,64,84-88 
 
The complication of stricturing after pancreatic duct stenting is mentioned in various 
studies however it is reported as asymptomatic in most series.34,64,85,87 Even Lin et al.86 
who cited it as a major concern had no patients requiring surgery after endoscopic 
intervention. The optimum duration of stenting is not known however it seems that 
prolonged stenting increases the incidence of strictures. 
 
The utility of ERP in the management of pseudocysts is well put forward by Buccimazza 
et al.21 and Lin et al.77 in their respective papers. In the clinical scenario of pseudocysts 
the effectiveness of ERP is easily quantifiable. 
 

























REVIEW ARTICLES OF ERP IN PANCREATIC TRAUMA 
 
Endoscopic retrograde pancreatography in pancreatic trauma: Need to break the 
mental barrier11 
 
Bhasin et al. from Chandigarh, India analysed seven studies looking at endotherapy for 
pancreatic trauma. The authors discuss ERP in its various contexts: diagnostic ERP, 
early therapeutic ERP and delayed therapeutic ERP in dealing with the complications of 
pancreatic trauma. The authors proposed an algorithm detailing the role of ERP in 
pancreatic trauma (Figure 5). 
 
 












The authors noted that published experience is in the form of case reports, retrospective 
case series and 2 studies published in abstract form only. The studies were comprised 
of small numbers. They felt that there is mental barrier to performing ERP in the early 
phase of polytrauma and that this needs to be overcome in order to assess the role of 
pancreatic stenting in pancreatic trauma. The utility of ERP in dealing with delayed 













SUMMARY OF INTRODUCTION 
 
Pancreatic trauma is a complex and challenging problem. The pancreas is difficult to 
treat and even in optimum circumstances the complication rate is significant. These 
complications relate to disruption of the main pancreatic duct. ERP serves to confirm 
the diagnosis and to offer different therapeutic options. The long duration of patient 
accrual, differences in classification of injuries and complications as well as the timing 
and method of endoscopic intervention make comparing these studies difficult. The 
recent addition of MRCP in assessing pancreatic ductal integrity adds another 
dimension to the interpretation of the data. The role for ERP in managing pancreatic 
trauma is evolving and varies between institutions. This introduction summarizes all the 
available data on the role of ERP in pancreatic trauma providing a framework with which 















Endoscopic retrograde pancreatography can define the extent of the main pancreatic 




The aim of this study was to describe the experience at our institution of complicated 
traumatic pancreatic injuries which required ductal assessment and possible 
intervention with ERP. Our data was analysed and our results compared to those in the 







We prospectively collected a database which included all patients who sustained a 
pancreatic injury and were treated at Groote Schuur Hospital (Level 1 equivalent trauma 
centre) from January 1983 to January 2010. All patients who underwent endoscopic 
retrograde pancreatography (ERP) were reviewed. Folders, radiological and laboratory 
investigations, operative and ERP notes were studied. Data was entered into a 
specifically formulated relational database. 
 
Variables documented included demographics, mechanism and date of injury, clinical 
presentation and delay in presentation, associated injuries, grade of pancreatic injury, 
amylase levels, surgical findings and management, complications and their 
management, ERP findings and management, duration of ICU stay, length of hospital 























*In the rare case of a devitalizing, destructive injury a pancreaticoduodenectomy may be 
required. These cases would be excluded from subsequent ERP management due to 
the nature of the operative resection. 
 
Injuries were graded as per the Pancreas Organ Injury Scale of the American 




An ERP was performed in any patient with a high suspicion of a pancreatic duct injury 
either clinically or radiologically and included patients with established pancreatic 
complications. This was carried out by an experienced interventional endoscopist in a 
dedicated ERP suite. The aim at ERP was selective pancreatic cannulation to define the 
injury site and nature of pathology, or to visualize endoscopic evidence of a pseudocyst. 
 
If a fistula was demonstrated an assessment was made as to the severity of leak. Minor 
leaks from peripheral ducts or the distal pancreas were treated conservatively. Major 
leaks were managed by sphincterotomy with stenting where feasible. 
 
Pseudocysts with an obvious bulge into duodenum or stomach underwent endoscopic 
drainage with cyst enteric stenting. If cystenteric drainage was not possible 
transpapillary drainage was attempted when technically feasible. Endoscopic ultrasound 
was not used during the study period.  
 
If a significant stricture or duct cut-off was demonstrated an attempt was made to pass a 
guidewire, stent the injury and await clinical resolution. If this failed and symptoms were 
minimal an expectant approach was undertaken. If endoscopic treatment failed to 














Image 1: Schematic representation of ERP procedure89 
 
If there was technical failure and it was thought that there could be a successful 
endoscopic intervention in the future ERP was repeated. 
 
Delayed surgical management 
 
If the decision to operate was made after ERP the operation was at the discretion of the 
surgeon doing the procedure guided by the ERP findings and other investigations. 
Options were distal pancreatectomy (+/- splenic preserving), cystgastrostomy, 
cystjejenostomy or pancreaticojejenostomy. 
 
Database and Statistical analysis: 
 
Data was entered into a password protected Microsoft Access 2007 database and 

















Forty-eight patients (42 men, 6 women; median age 29 years, range 15-68) underwent 
ERP for pancreatic trauma from a database of 417 traumatic pancreatic injuries. 
 
Mechanism of injury: 
 
Twenty-six patients had sustained blunt injury due to assault (n=19), motor vehicle 
accidents (n=5), and one each from a fall from a height and a rugby tackle.  Twenty-two 
penetrating injuries were due to gunshots (n=15) and stabs (n=7). Twenty-nine patients 
had associated injuries. The majority of blunt pancreatic injuries, were isolated injuries 
(n=19). 
 
Delay to presentation: 
 
Thirty patients presented within 24 hours of their injury, a further 8 in the following week 




Thirteen of the 48 patients were treated non-operatively. Thirty-five underwent an initial 
laparotomy. Of the 31 pancreatic injuries identified intra-operatively simple drainage 
was performed in 23, while 7 patients had a distal pancreatectomy and one had a cyst-
gastrostomy.  
 
Of the 23 patients treated with initial drainage of their pancreatic injury 3 went on to 
have further pancreatic surgery. Two of these patients required surgery for pancreatic 
fistulae originating from the body of the pancreas while the other required surgery for a 












pancreatic resection at their initial operation. Drainage was the only appropriate 
management option for the remaining patient who had an injury to the head of the 
pancreas and underwent 2 damage control operations in the acute setting.   
 
There were 4 missed pancreatic injuries all in patients with penetrating trauma. One of 
these had two damage control laparotomies and the pancreatic injury presented 4 
months later as chronic pancreatitis secondary to a pancreatic stricture. One patient had 
a nephrectomy done at a peripheral hospital complicated by a large pancreatic fluid 
collection which was drained at relook laparotomy. One patient had a small bowel repair 
at a peripheral hospital and returned 3 weeks later with a symptomatic pseudocyst. One 
patient had a diagnostic laparoscopy following a stab wound which found only blood 
and presented with a gastric outlet obstruction 16 days later. 
 
Of the 13 patients who were initially managed conservatively 6 presented to hospital 
acutely of who 3 had a pancreatic injury recognized on admission. In the other 3 acutely 
hospitalized patients the pancreatic injury was missed initially. The remaining 7 patients 
treated conservatively had a delay of more than a week from the time of injury to their 




Serum amylase was done in 22 patients who had an average level of 1558u/l (range 94-
4200u/l) and was suspicious of pancreatic injury in 19 of the 22. A further 17 patients 
had fluid (fistula fluid or aspiration of intra-abdominal collection) sent for amylase 
determination and this ranged from 10000 to 291300u/l (average 89000u/l) all deemed 



















Injuries were graded using the Pancreas Organ Injury Scale of the American 
Association for the Surgery of Trauma24 based on the operative and radiological 
findings (Table 9).  
 
Table 9: AAST grading of pancreatic injury 
AAST Number of patients Acute Delayed 
Grade I 2 2 0 
Grade II 4 3 1 
Grade III 30 24 6 
Grade IV 11 8 3 
Grade V 1 1 0 
 
The majority of injuries were Grade 3 (n=30) or more (Grade 4: n=11; Grade 5: 
n=1)).Only 6 patients had minor injuries Grade 1 (n=2) or Grade 2 (n=4).The site of 
pancreatic injury was head (n=16), neck (n=6), body (n=16) and tail (n=9). In one 













More than half (n=29) of patients had associated injuries (Table 10). The likelihood of 
associated injuries correlated with the mechanism of injury. All penetrating trauma 
patients had 1 or more associated injuries. One patient with an abdominal stab had 
omentum reduced at initial presentation, was treated conservatively but represented 
later with a gastric outlet obstruction secondary to pancreatic pseudocyst.  
Table 10: Associated injuries related to mechanism of injury 
Organ Injured Total Penetrating Blunt 
Liver 12 11 1 
Stomach 10 10 0 
Colon 10 8 2 
Kidney 8 5 3 
Small bowel 5 4 1 
Duodenum 5 5 0 
IVC 5 5 0 
Chest 5 5 0 
Spleen 5 4 1 
Diaphragm 4 4 0 
Limbs 3 3 0 
Spine 3 3 0 
Head 1 0 1 
The mean number of associated injuries in the penetrating trauma group was three 
(range 0 -7). In the blunt trauma group the number of associated injuries ranged from 0 












There were 19 isolated pancreatic injuries. These only occurred in blunt trauma 
patients. Twelve presented acutely and 7 had a delayed presentation. Their average 
hospital stay was 25 days (range 1 - 65) similar to the rest of the patients in this study. 
Within this group were the only eight patients who did not have an operation at any 
stage of their management.  
Nutritional support: 
Fourteen patients received total parenteral nutrition during the course of their 
management. Enteral nutritional support was not recorded.
Complications: 
There were a total of 106 complications at an average of 2.2 per patient (range 1 - 5).
Of the pancreatic complications fistulae were the most common (n=30) followed by
pseudocyst (n=10), acute pancreatic fluid collections (n=8) and pancreatitis (n=7). Some
pancreatic complications diagnosed clinically and radiologically resolved prior to the use
of ERP. The most common extra-pancreatic complications were abdominal sepsis 













Table 11: Number of complications 
Complication Number 
Pancreatic  
Pancreatic fistula 30 
Pseudocyst 10 
Acute pancreatic fluid collection 8 
Pancreatitis 7 
Non-pancreatic  
Abdominal sepsis 12 
Respiratory 8 
DIC 4 
Wound infection 4 
Gastric outlet obstruction 2 
Pleural effusion 2 
Adhesive  obstruction 1 
Urinary tract infection 1 
Abdominal compartment syndrome 1 
Enterocutaneous fistula 1 
Biliary fistula 1 
DVT 1 
Anastomotic failure 1 
  
Percutaneous radiological interventions: 
 
Twelve patients had percutaneous drains placed. One was a definitive procedure after 
an ERP demonstrated an intact main pancreatic duct. Eleven drainage procedures were 















A total of 74 ERPs were attempted on 48 patients (Figure 7). In 12 cases there was 
initial failure to cannulate the pancreatic duct due to adverse conditions (swollen papilla, 
distorted anatomy) however a subsequent attempt was successful in 11. One patient 
who did not have a diagnostic ERP went on to have a distal pancreatectomy. Additional 
ERPs were for changing of stents in 4 patients, stent removal in 6, checking for a leak in 
4 and for a new pancreatic complication in 1.  
Figure 7 shows the pathology demonstrated at ERP and Table 12 shows the
management specific to the ERP diagnosis.
Figure 7: Pathology demonstrated at ERP 
* Patient had a distal pancreatectomy.
** Patient clinically had a pancreatic fistula however no leak was demonstrated. A
sphincterotomy was performed and the fistula resolved.
The pathology listed is the primary pathology demonstrated at ERP as some crossover 
between the groups was possible. One patient who had dual pathology (a fistula 
followed later by a pseudocyst) is placed only in the fistula group and is discussed 
under complications. 
48 
Patients 1 Failed ERP*
47 Diagnostic ERPs 1 No pathology** 
24 Pancreatic 
fistulae 



















    
Minimally invasive    
    Conservatively treated 5 3 2 
    Sphincterotomy 12* 1 0 
    Stenting 6 1 0 
    Endoscopic drainage 0 0 6 
    Percutaneous drainage 0 0 1 
Total  23 5 9 
    
Surgery    
    Distal pancreatectomy  2 4 0 
    Pancreaticojejunostomy  0 3 0 
    Cystjejunostomy 0 0 1 
Total operations 2 7 1 
    
 
*One patient had a clinical fistula (fluid amylase = 291300u/L) but no demonstrable leak 
at ERP. This patient had a pancreatic sphincterotomy and the fistula did resolve. 
 
ERP provided information which was used to determine management in 47 patients. 
Ten patients were treated conservatively following ERP. Nine of these had 
uncomplicated resolution of their pancreatic complication. One patient with a pancreatic 
fistula re-presented with a pseudocyst. This was successfully managed with transmural 
endoscopic drainage. 
 
When stenting was attempted this was technically successful in only 1 of 9 patients with 
strictures/duct cut-off and in 6 of the 19 fistula patients. In 6 patients with successful 












from injury to stent placement of 27 days. In the 21 failures of stent placement there 
was a longer average delay from injury to ERP of 48 days. 
 
Endoscopic assessment of a pseudocyst led to cystenteric drainage in 6 patients. One 
pseudocyst recurred and required repeat endoscopic drainage. Two patients with no 
visible bulge endoscopically and an intact pancreatic duct were treated successfully 
conservatively. One patient with severe symptoms, a disrupted duct and no visible 
endoscopic bulge proceeded to surgery and had a cyst-jejunostomy.  
 
The decision to operate based on the ERP findings was carried out in 8 of 10 patients 
earmarked for surgery after ERP. One patient with a fistula was scheduled for a distal 
pancreatectomy, however in the three month wait for his operation the fistula had 
resolved. He had had a sphincterotomy at initial ERP. In another patient surgery was 
performed but abandoned due to dense adhesions. He had had an initial stent placed, 
later exchanged for a larger one, which was felt to be unsatisfactory. His fistula resolved 
28 days after his abandoned operation. 
 
Complications of ERP: 
 
There were two episodes of self-limiting pancreatitis following ERP. One patient had a 
bleeding sphincterotomy which was successfully managed by injection sclerotherapy. 
One patient was lost to follow up with a stent in situ. Of the patients undergoing surgery 
after ERP there were 4 complications, none of which were pancreatic.  
 
Time to ERP: 
 
There was a significant delay from time of injury to ERP in most patients, performed on 
average 38 days after the initial injury (range 2 - 365 days). ERP was carried out on 













Hospital stay and follow-up: 
 
Average length of hospital stay was 29 days (range 1 - 86 days). Time from ERP to 
hospital discharge was on average 9 days (range 0 - 54 days). Long term follow-up was 
not conducted beyond the resolution of pancreatic pathology. There were no deaths in 















Pancreatic trauma is an uncommon injury and this study took 27 years to accrue 48 
patients who underwent ERP. All published series of more than 15 patients took over 10 
years to accumulate pancreatic trauma patients undergoing ERP.  
 
Table 13 shows our results in the context of previously published studies. Thirteen 
studies were analysed with a total of 147 patients undergoing ERP. Fifty-one patients 
proceeded to surgery after their ERP. However it must be noted that the studies 
performed prior to 2000 were of a purely diagnostic nature and surgery offered the only 
form of treatment for major pancreatic disruption at this time. Excluding these studies 
shows that from 2001 onwards ERP was performed in 101 patients and was followed by 
an operation in 31 patients (28%). Our own rate of operation after ERP was 20% and 
can possibly be explained by a high perseverance rate with endoscopic intervention 
with 26 repeat ERPs being performed. This is only surpassed by Kim et al.84 who 
carried out 32 procedures in 6 patients for stenting of pancreatic duct disruption and 
reported 4 severe strictures upon stent removal. The duration of stenting should be 
reduced to prevent this complication.  
 
Endoscopic interventions across these 10 studies included 47 patients who had stents 
placed, 14 patients where endoscopic drainage of a pseudocyst was performed  and 7 
patients who had a pancreatic sphincterotomy. In our study we placed 7 stents, 6 
patients had pseudocysts drained endoscopically and 14 patients had a sphincterotomy 
alone. The inability to pass pancreatic stents could be attributed to the marked delay 
between injury and ERP, a mean of 38 days in our study. ERP being performed a mean 
of 22 days after hospital admission. In pancreatic trauma there can be an insidious 
onset before the pancreatic injury becomes manifest and it is important for the primary 
treating physician to maintain a high index of suspicion.  
 
In our study ERP was used in patients with established pancreatic complications and 
























duct injury compared to 60 - 69% in the two largest studies in the literature.84, 87 The 
majority of pancreatic injuries were detected operatively within 24 hours due to the need 
for emergency laparotomy. A delay in diagnosis of pancreatic injury is associated with 
increased morbidity and mortality with Kim et al.84 reporting that a delay in ERP 
assessment of the duct resulted in an increased pancreatic complication rate. The 
frequent occurrence of associated injuries complicates the assessment of pancreatic 
morbidity and mortality. In our series 19 patients with isolated pancreatic injuries had a 
hospital stay of 25 days compared to 29 days in the patients with associated injuries. 
This seems may suggest that it is the morbidity of the pancreatic complications which 
prolongs the hospital stay. 
 
The timing of ERP in pancreatic trauma has evolved over time. Initially an early ERP 
was used to help assess the integrity of the pancreatic duct and guide the need for 
surgery.84 Since the advent of therapeutic ERP the number of patients having an 
endoscopic intervention in the acute setting is small with less than 30 patients across 7 
studies.34, 64, 84-88 More recent studies report a greater proportion of patients undergoing 
delayed ERP with established pancreatic complications.34, 87 The average length of 
hospital stay in our series was 29 days and this compares to Kim et al. who reported an 
average of 20 days in their early ERP group and 43 days in their delayed ERP group 
although this was not statistically significant. 84 Effectiveness of ERP assessments and 
interventions is hard to judge as the natural history of pancreatic fistulae is poorly 
defined. This is illustrated by 2 of our patients who had main pancreatic duct injuries 
which were assessed as not amenable to endoscopic treatment. Both patients had 
complete resolution of their pancreatic fistulae after a month of conservative therapy 
despite the planned surgery not being performed.  
 
Minor pancreatic injuries (Grade I and II) do well with conservative treatment15 so the 
need for endoscopic treatment of these injuries is questionable. Canty and Weinman64 
reported on endoscopic stenting in two children with this type of injury who ultimately did 
well. However these authors did also report duct stricturing and this remains a concern 












parenchymal injuries is therefore prudent. For more severe injuries treated by stenting 
there is a marked variation in the length and calibre of stents used as well as the 
duration of stenting which further complicates the assessment of this intervention.11       
 
Although only one ERP was ultimately unsuccessful in contributing any information to 
patient management eleven patients had to undergo a second procedure to delineate 
the pancreatic duct. This attests to the difficulty of selective pancreatic cannulation in 
this group of patients. Historically patients who had an ERP showing an intact 
pancreatic duct were spared surgery and this was reported as an ERP success. In the 
modern era with increasing access to MRCP this should no longer be valid. In early 
studies by Barkin et al.81 and Whittwell et al.82 15 of 23 patients had completely normal 
ducts and were exposed to the potential complications of ERP.80  
 
MRCP was not used in our series but could possibly have made a difference in eleven 
patients, one with no ductal disruption on ERP and ten with conservatively treated 
injuries. When available MRCP is a valuable adjunct in assessing the pancreatic duct 
injury and is complication free. There is limited published data on MRCP related to 
pancreatic trauma. Houben et al. had seven children of whom three were successfully 
spared further intervention on the basis of the MRCP findings.34 Gillam et al. reported 
on eight trauma patients with four spared further intervention.33  MRCP is placed before 
ERP in a recently published algorithm dealing with pancreatic trauma in patients with a 
high suspicion of ductal injury.11 In patients with a demonstrated minor ductal disruption 
its accuracy in stratifying patients into conservative or interventional management still 
needs to be assessed. Patients with an intact pancreatic duct on MRCP can however 
be safely observed without ERP and its use is justified in order to avoid the potential 
complications of ERP in these patients. 
 
ERP may reduce the need for surgery if endoscopic therapy is successful. In our series 
pancreatic fistulae and pseudocysts were most likely to be resolved by this minimally 
invasive approach (19 of 24 fistulae and 6 of 10 pseudocysts). These are the most well 











fistulae and pseudocysts the patient’s response to the injury has localized the 
inflammatory process. If the pancreatic ductal disruption can be dealt with, or a new 
communication made, endoscopic results are good. In these pathologies ERP should 
be a therapeutic option before surgery. 
It is the heterogeneous group of patients with strictures or complete duct cut-off who are
difficult to manage. They present with acute fluid collections, pancreatic ascites or later 
with chronic pancreatitis. In our series surgery was required in the majority of these
patients due to the unsatisfactory nature of their endoscopic intervention. There was 
only one successful stent placement in this group with 7 of 12 patients proceeding to
surgery.
In our series the overall success rate of therapeutic ERP was 28 of 38 (73%) when the
10 patients treated conservatively based on ERP findings were excluded. This
compares to 12 of 19 (63%) by Rogers et al.87
We did not note a significant pancreatic stricture rate from ERP as reported by Lin et
al.86 One patient returned with a symptomatic pseudocyst following pancreatic fistula
resolution and one patient with a pseudocyst had a recurrence following endoscopic 
drainage. Both were managed by endoscopic drainage. Follow-up was limited and one
patient was lost to follow-up with a pancreatic duct stent still in situ.
The lack of mortality in the study group can be attributed to the delayed use of ERP, a 
mean of 22 days after admission. This allowed complications to be established rather 
than attempting to pre-empt them in the acutely ill patients. The complication rate is 
linked to the delay from time of injury to detection of main pancreatic duct disruption. It 
is these MPD injuries which need to be definitively dealt with or they will invariably 
complicate. The patients in our series stayed in hospital a mean of 9 days after ERP.  
The earlier use of ERP could potentially result in a reduction in hospital stay and the 
timing of needs to be studied as an end-point in future studies. The delay noted from 












service as well as a lack of awareness regarding the utility of ERP in treating pancreatic 
complications amongst treating physicians. 
 
The distinction between a pseudocyst and an acute fluid collection is often not made in 
the literature and this has implications for management strategy. Without an established 
wall the treatment options are expectant, percutaneous or endoscopic . We have not 
analysed the implications of ERP in the context of acute fluid collections due to the 
significant delay to undergoing ERP. In order for future studies to accurately assess the 
utility of ERP in the acute setting these collections need to be accurately defined. 
 
We did not analyse the role of CT scanning to diagnose pancreatic injuries in the acute 
setting as it was not consistently performed throughout the study period. Houben et al.34 
compared CT scan findings to ERP findings and found it suggestive of pancreatic injury 
in 10 of 11 patients. However its accuracy in assessing the grade of injury was not 
reported and there was one false positive which was erroneously labelled as a grade IV 
injury. Kim et al.84 reported a 55% success rate of CT scan in predicting a main 
pancreatic duct injury. They also reported two false positives and three cases where the 
injury was inaccurately graded. CT detection of pancreatic injuries is not very sensitive 
or specific and it is relatively unreliable in grading the pancreatic injury although this has 
improved in more recent studies.90 CT is the investigation of choice for certain other 
abdominal organ injuries and as such should feature in a management algorithm 
dealing with pancreatic trauma despite its limitations in assessing the pancreas.11        
 
Our operative success in detecting a pancreatic injury was 31 of 35 (89%). This was 
similar to that previously reported in international literature of 84%10 to 100%21. The 
majority (73%) of injuries in our series warranted operative therapy on presentation due 
to a high proportion of penetrating injuries and their increased rate of emergency 
laparotomy. Rogers et al.87 reported a 54% emergency laparotomy rate in their series of 













Accurate assessment of pancreatic injuries intra-operatively with appropriate surgical 
management reduces the risk of pancreatic complications.28 In our series the initial 
surgical management of the acute pancreatic injury was by simple drainage of the 
pancreas in 23 patients while 7 patients had a distal pancreatectomy. Two patients with 
initial pancreatic drainage who ultimately underwent distal pancreatectomy could 
potentially have had a pancreatic resection at their initial operation, a possible error in 
surgical judgement. In one patient, who later required a pancreaticojejenostomy to 
resolve a pancreatic stricture, the initial surgical option of drainage was appropriate 
given the location of the injury in the pancreatic head and the clinical situation of 2 
damage control operations and a protracted course in intensive care. It should be noted 
however that pancreatic resection in the trauma setting has a recognized pancreatic 
complication rate of 12%.53 
 
Injuries were distributed throughout the 4 parts of the pancreas and were mostly Grade 
III and IV injuries which again emphasizes that it is the integrity of the pancreatic duct 
which is linked to the development of pancreatic complications. Minor injuries do well 
with conservative treatment and one has to question the benefit of immediate ERP in 
patients with minor ductal disruptions which may heal spontaneously. Some authors 
present favourable outcomes with endoscopic intervention in patients with essentially 
minor injuries.64 The natural history of minor duct injury is not known and prolonged duct 
stenting has been reported to lead to stricturing.86 We feel that the extent of intervention 
in the setting of a minor injury should be limited to a pancreatic sphincterotomy.  
 
In our study intravenous nutritional support was seldom required and we feel its use 
should be limited to patients with intestinal failure and not used as a treatment of 
pancreatic complications. Its routine use in fistula management is not an international 
standard and necessitates prolonged hospital stay which may not alter outcome. In the 
series by Houben et al.34 it was used in 11 of 15 patients for a mean of 28 days with the 
authors citing their cautious approach to oral nutrition as a reason for the prolonged 












predominantly due to penetrating trauma who all settled on conservative treatment, with 




Some of the limitations of this study are inherent due to of the long duration required to 
accrue patients with a rare injury. Technology and practices have evolved during the 
study period. Specifically MRCP and the additional utility of endoscopic ultrasound were 
not assessed. Early therapeutic ERP, which was not done due to significant delays in 
referral and diagnosis, is an aspect which we were unable to study. In keeping with all 
trauma related studies there was limited long-term follow-up. 
 
The use of ERP for pancreatic trauma is evolving. Its diagnostic and therapeutic utility is 
proven. The diagnostic role will change with the increasing availability and use of 
MRCP. However the interventions offered at ERP provide an effective means of dealing 
with various pancreatic complications. This is especially true with pancreatic fistulae and 
pseudocysts but less so with pancreatic strictures or duct cut-off. The use of ERP in the 
setting of delayed complications of pancreatic trauma is both prudent and practical. 
ERP helps guide management and in many cases offers a minimally invasive solution 
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The role of endoscopic retrograde pancreatography in the management of 
pancreatic trauma 
Principle investigator: Dr DA Thomson 
Supervisor: Prof JEJ Krige, Prof PC Bornman 
INTRODUCTION 
The integrity of the main pancreatic duct is the most significant factor in predicting 
pancreatic morbidity in traumatic injury of the pancreas.(Subramanian,Dente & 
Feliciano, 2007, Krige and others, 2005) Endoscopic retrograde pancreatography (ERP) 












duct.(Bhasin,Rana & Rawal, 2009) It is however an invasive procedure carrying its own 
significant morbidity and mortality.(Bilbao and others, 1976) It does however also offer a 
therapeutic management option in the management of pancreatic injury and its 
complications. 
There are only seven studies in the world literature examining the role of ERP in 
pancreatic trauma, all with relatively small numbers. 
Author  Year  Journal  No. of patients  
Davila et al.  1997  Gastrointestinal Endoscopy  9  
Canty & Weinman  2001  Journal of Paediatric Surgery  2  
Delcenserie et al.  2001  Gastrointestinal Endoscopy  13  
Wolf et al.  2005  Surgical Endoscopy  2  
Lin et al.  2006  Surgical Endoscopy  6  
Houben et al.  2007  Journal of Paediatric Surgery  11  
Rogers et al.  2009  Journal of Trauma  26  
 
Table 1: Papers examining the role of ERP in pancreatic trauma. (Davila,Rogers & 
Cello, 1997)(Delcenserie,Barthet & Yzet, 2001, Wolf and others, 2005, Lin and others, 
2006, Houben and others, 2007, Rogers,Cello & Schecter, 2009) 
Since 1983 Groote Schuur Hospital has kept a database on all patients with pancreatic 
trauma. In the same year the first ERP was done at Groote Schuur hospital. In the 
Western Cape our position as a Level 1 trauma centre with a high trauma burden and 
as the tertiary centre for ERP leaves us well positioned to evaluate our use of ERP in 
pancreatic trauma. 
 AIM 
We aim to define the role of ERP in the management of traumatic injury to the 
pancreas. 
PATIENTS AND METHODS 
This is a retrospective audit of a prospectively collected database of all patients who 
sustained a traumatic injury to the pancreas and who underwent ERP from January 













Patients who underwent ERP for bile duct or liver injury are excluded from analysis.  
Study design: 
Data collected will be: Demographics, mechanism and date of injury, clinical 
presentation and delay in presentation, revised trauma score, associated injuries, 
amylase levels and radiological investigations, initial management, associated 
complications and their management, ERP findings and subsequent treatment, outcome 
of endoscopic therapy, number of repeat endoscopic procedures, grade of pancreatic 
injury, duration of ICU stay, length of hospital stay, morbidity and mortality. 
Upon analysis we wish to review the demographics of pancreatic trauma patients 
undergoing ERP, review their mechanism of injury and associated injuries and their 
mode of presentation and clinical management. Diagnostic tools, surgical management 
and complications will be analysed with particular focus on the utility of ERP. Patient 
outcomes will then be looked at and our practices compared with those in the 
international literature. 
ETHICS 
Each patient will be given a unique identifier and data stored in a password protected 
database. This study will be conducted in accordance with the Declaration of Helsinki - 
2008. (Williams, 2008) 
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